Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American…
HONG KONG, Aug. 28, 2025 /PRNewswire/ -- "Hong Kong, our advantage is you and the ICAC". For nearly two decades, the…
- Phase 3 Trial Informed by KARDIA-3 Phase 2 Study Results Presented as a Late-Breaking Abstract at the European Society…
Positive Trial Demonstrates Superiority of Aficamten to Standard-of-Care Beta-Blocker Metoprolol Primary Endpoint Result Consistent Across All Prespecified Subgroups Company to…
- The 'Pragati: AI for Impact' convening saw the participation of 150+ key stakeholders from corporates, civil society, policymakers and…
Pioneering solution provides scientists with actionable answers faster to accelerate scientific discovery COLUMBUS, Ohio, Aug. 4, 2025 /PRNewswire/ -- CAS,…
Houston, Texas, July 18, 2025 (GLOBE NEWSWIRE) -- In a groundbreaking development, Topnotch Crypto, a London-based blockchain innovator, is transforming…
The competition features three tracks covering AI security technologies on images, videos, and audio, with a total prize pool exceeding…
GENEVA, July 10, 2025 /PRNewswire/ -- ZTE Corporation (0763.HK / 000063.SZ), a global leading provider of integrated information and communication technology…
LITTLE ROCK, Ark., July 04, 2025 (GLOBE NEWSWIRE) -- The Dermatology Group of Arkansas are thrilled to welcome their newest,…